Skip Navigation LinksHome > May 2010 - Volume 16 - Issue 3 > Emerging epidemic of drug-resistant tuberculosis in Europe,...
Current Opinion in Pulmonary Medicine:
doi: 10.1097/MCP.0b013e328337573e
Infectious diseases: Edited by Alimuddin Zumla

Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives

Migliori, Giovanni Battistaa; Centis, Rosellaa; Lange, Chrisb; Richardson, Morgan D'Arcyc; Sotgiu, Giovannid

Collapse Box


Purpose of review: Drug resistance, particularly through multidrug-resistant tuberculosis (TB) and extensively drug-resistant TB strains, poses a real threat to TB control worldwide. Recent reports from the WHO and the International Union Against Tuberculosis and Lung Disease demonstrate that the emerging epidemic of drug-resistant TB is a global problem, although emphasis has been placed on several ‘hot spots’ because of lack of good global data.

Recent findings: The present article is aimed at reviewing the available information on drug-resistant TB with special focus on the features of the epidemic in Europe, Russia, Latin America, Asia and specifically China, and to discuss the global perspectives related to drug-resistant TB control and care.

Summary: Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs and other reasons related to prescribers, patients and drug producers. Although there is an urgent need for new drugs, a sound public health approach is necessary for their introduction in clinical treatment settings to prevent/avoid creating additional resistance, as has already been observed for first and second-line anti-TB drugs in many settings.

© 2010 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.